RT @biorxiv_cellbio: Neuropilin 2 stabilises adherens junctions and protects against endothelial activation by promoting the interaction be….

RT @M_MorganLab: Very excited to share our latest paper describing crosstalk between αvβ6 integrin & HER2 in breast cancer invasion & drug….

RT @nteng18: Paper from my #PhD is out! We profiled the gut and oral #microbiome of metastatic #breastcancer patients. This project was a l….

RT @DanielFigeys: Delighted to share that I’ll be joining the @QuadramInstitute as Director & CEO in April 2025! I am honoured to work with….

RT @hall_lab: 🥳I'm incredibly honoured to receive the @MicrobioSoc Peter Wildy Prize 2025 for #scicomm, a true team prize! Huge thanks to t….

RT @drvolts: I'm glad I don't have to write an endorsement piece, because I really wouldn't know how to go about it. Ever since 2015, when….

RT @hall_lab: 🚨 Exciting opportunity at @unibirmingham @unibirm_CMH! 🚨 Offering a 2-year Springboard Fellowship designed to support high-ca….

RT @hall_lab: Check out this exciting thread featuring a new preprint from @RobinsonLab_QIB 👇.Thrilled to share our collaborative study on….

Check out the full preprint for more details! 🧬 #cancerimmunology:.

3/ Think of it as bacteria with a “sweeter” edge - the sugars in the EPS are driving immune responses that fight tumours. This unique mechanism positions Bifidobacterium EPS as a potential new class of therapeutic compounds in cancer treatment. 💥 #immunotherapy.

2/ A standout feature? The bacterial capsular EPS produced by B. pseudocatenulatum 210. EPS activates dendritic cells and boosts systemic cDC1 infiltration, triggering a powerful CD8+ T cell-mediated anti-tumour response. 🍬🦠.

1/ Gut microbes have long been recognised as key regulators of cancer responses. Our study highlights the potential of B. pseudocatenulatum to inhibit breast cancer progression, enhancing the efficacy of standard therapies in pre-clinical mouse models.

🧵 Exciting new preprint! 🚨 We’ve uncovered how Bifidobacterium pseudocatenulatum capsular exopolysaccharides (EPS) can enhance systemic anti-tumour immunity in pre-clinical breast cancer models. Here's what we found 👇 #cancerresearch #microbiome.

RT @hall_lab: SO pleased to see this study now published @MolMetab - led by the fantastic @JLopTello! Jorge is currently setting up his ow….

RT @prideukorg: 👏👏👏

RT @CommsBio: In vitro and in vivo data demonstrate neuropilins regulate the trafficking of alpha5-integrin in endothelial cells. @Robinson….

RT @HapsirN: @JCIHorton @pintofscience Dr. Chris Price from @RobinsonLab_QIB @TheQuadram talks about why he studies gut bacteria & how bact….

RT @TheQuadram: We’re looking for a Research Scientist to join @RobinsonLab_QIB to work on a @BreastCancerNow funded project examining the….

RT @TheQuadram: Do you have a PhD in cell or molecular biology with previous experience in bioinformatic analyses of microbiota samples?🧬….

RT @WHusseyAuthor: To celebrate the publication of the KILLING JERICHO paperback, I’m giving away a SIGNED & DEDICATED copy of the hardback….